HEADER TRANSFERASE 30-JAN-09 2W9Z TITLE CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: G1/S-SPECIFIC CYCLIN-D1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 16-271; COMPND 5 SYNONYM: PRAD1 ONCOGENE, BCL-1 ONCOGENE, D-TYPE CYCLIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CELL DIVISION PROTEIN KINASE 4; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: CYCLIN-DEPENDENT KINASE 4, PSK-J3, CDK4; COMPND 11 EC: 2.7.11.22; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 15 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, CYCLIN DEPENDENT KINASE, TRANSFERASE ONCOLOGY, CELL KEYWDS 2 CYCLE, DRUG DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR P.J.DAY,A.CLEASBY,I.J.TICKLE,M.O.REILLY,J.E.COYLE,F.P.HOLDING, AUTHOR 2 R.L.MCMENAMIN,J.YON,R.CHOPRA,C.LENGAUER,H.JHOTI REVDAT 4 13-DEC-23 2W9Z 1 REMARK REVDAT 3 24-APR-19 2W9Z 1 SOURCE REVDAT 2 31-MAR-09 2W9Z 1 JRNL REVDAT 1 10-MAR-09 2W9Z 0 JRNL AUTH P.J.DAY,A.CLEASBY,I.J.TICKLE,M.O'REILLY,J.E.COYLE, JRNL AUTH 2 F.P.HOLDING,R.L.MCMENAMIN,J.YON,R.CHOPRA,C.LENGAUER,H.JHOTI JRNL TITL CRYSTAL STRUCTURE OF HUMAN CDK4 IN COMPLEX WITH A D-TYPE JRNL TITL 2 CYCLIN. JRNL REF PROC.NATL.ACAD.SCI.USA V. 106 4166 2009 JRNL REFN ISSN 0027-8424 JRNL PMID 19237565 JRNL DOI 10.1073/PNAS.0809645106 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.1.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 94.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 26174 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1291 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.60 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.82 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4200 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2446 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3991 REMARK 3 BIN R VALUE (WORKING SET) : 0.2413 REMARK 3 BIN FREE R VALUE : 0.3066 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.98 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 209 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4230 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 222 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.42 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 63.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.45926 REMARK 3 B22 (A**2) : 5.46453 REMARK 3 B33 (A**2) : 4.99473 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. DISORDERED REGIONS WERE MODELLED STEREOCHEMICALLY REMARK 3 WHERE POSSIBLE REMARK 4 REMARK 4 2W9Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-JAN-09. REMARK 100 THE DEPOSITION ID IS D_1290038634. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.931 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26174 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 94.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.42000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1BLX REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.59900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 94.34950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.50550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 94.34950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.59900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.50550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2620 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLY 43 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLY 44 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, THR 172 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 15 REMARK 465 ALA A 16 REMARK 465 TYR A 17 REMARK 465 PRO A 18 REMARK 465 ASP A 19 REMARK 465 ALA A 20 REMARK 465 ASN A 21 REMARK 465 PRO A 268 REMARK 465 LYS A 269 REMARK 465 ALA A 270 REMARK 465 ALA A 271 REMARK 465 MET B 1 REMARK 465 ASP B 241 REMARK 465 VAL B 242 REMARK 465 SER B 243 REMARK 465 LEU B 244 REMARK 465 HIS B 296 REMARK 465 LYS B 297 REMARK 465 ASP B 298 REMARK 465 GLU B 299 REMARK 465 GLY B 300 REMARK 465 ASN B 301 REMARK 465 PRO B 302 REMARK 465 GLU B 303 REMARK 465 HIS B 304 REMARK 465 HIS B 305 REMARK 465 HIS B 306 REMARK 465 HIS B 307 REMARK 465 HIS B 308 REMARK 465 HIS B 309 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 109 C - N - CD ANGL. DEV. = -23.7 DEGREES REMARK 500 PRO B 113 C - N - CD ANGL. DEV. = -18.8 DEGREES REMARK 500 PRO B 233 C - N - CD ANGL. DEV. = -13.2 DEGREES REMARK 500 PRO B 239 C - N - CD ANGL. DEV. = -36.2 DEGREES REMARK 500 PRO B 251 C - N - CD ANGL. DEV. = -15.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 170 127.33 -177.94 REMARK 500 PHE A 223 71.19 -110.00 REMARK 500 GLN A 264 27.12 -57.75 REMARK 500 MET A 266 -103.19 -101.22 REMARK 500 ARG B 5 -16.40 -47.90 REMARK 500 PRO B 8 151.42 -49.45 REMARK 500 HIS B 27 1.70 -67.61 REMARK 500 LEU B 63 -24.76 177.37 REMARK 500 THR B 83 -114.58 -105.30 REMARK 500 ASP B 84 -13.31 -155.03 REMARK 500 ARG B 101 -70.03 -62.89 REMARK 500 LYS B 106 42.52 -61.04 REMARK 500 PRO B 108 15.95 -65.75 REMARK 500 PRO B 110 88.46 -66.39 REMARK 500 LEU B 112 -179.92 178.76 REMARK 500 ARG B 139 -18.22 80.62 REMARK 500 VAL B 148 106.19 177.53 REMARK 500 VAL B 154 96.52 61.26 REMARK 500 MET B 169 1.94 -67.03 REMARK 500 PRO B 173 170.16 -58.39 REMARK 500 VAL B 175 -155.55 45.46 REMARK 500 VAL B 176 -163.54 162.76 REMARK 500 THR B 177 46.87 166.61 REMARK 500 LEU B 178 2.32 -48.29 REMARK 500 GLN B 188 -99.61 -142.63 REMARK 500 SER B 189 47.21 162.01 REMARK 500 TYR B 191 -8.58 50.05 REMARK 500 ALA B 192 -175.67 -61.36 REMARK 500 GLU B 206 -17.41 -49.53 REMARK 500 ARG B 209 -140.18 -104.56 REMARK 500 ARG B 210 61.06 -160.15 REMARK 500 LYS B 211 165.91 167.36 REMARK 500 PRO B 212 120.74 -28.93 REMARK 500 ASN B 217 -68.89 -157.79 REMARK 500 LEU B 223 -72.81 -62.96 REMARK 500 GLU B 235 170.31 -53.23 REMARK 500 ASP B 237 14.50 -54.32 REMARK 500 PRO B 239 -169.03 -127.96 REMARK 500 PHE B 249 -156.80 -153.23 REMARK 500 PRO B 251 101.49 -51.65 REMARK 500 PRO B 254 87.37 -64.84 REMARK 500 PRO B 256 170.69 -56.51 REMARK 500 VAL B 257 -172.79 -58.69 REMARK 500 PRO B 262 -176.43 -57.71 REMARK 500 GLU B 265 -169.15 -101.37 REMARK 500 GLU B 266 -81.64 -45.55 REMARK 500 LEU B 276 51.26 -104.51 REMARK 500 LEU B 290 11.19 -62.44 REMARK 500 GLN B 291 34.85 -152.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE B 208 ARG B 209 149.70 REMARK 500 ARG B 209 ARG B 210 149.29 REMARK 500 ALA B 248 PHE B 249 -140.44 REMARK 500 GLN B 258 SER B 259 147.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2015 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH A2025 DISTANCE = 6.71 ANGSTROMS REMARK 525 HOH A2057 DISTANCE = 6.20 ANGSTROMS REMARK 525 HOH B2011 DISTANCE = 6.42 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2W99 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN REMARK 900 RELATED ID: 2W96 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN REMARK 900 RELATED ID: 2W9F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN REMARK 900 RELATED ID: 1LD2 RELATED DB: PDB REMARK 900 THEORETICAL STRUCTURE OF HUMAN CYCLIN- DEPENDENT KINASE 4(CDK4) REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 15-271 ARE EXPRESSED REMARK 999 MUTATIONS G43E G44E T172A DELETION 45 46 47 DBREF 2W9Z A 15 15 PDB 2W9Z 2W9Z 15 15 DBREF 2W9Z A 16 271 UNP P24385 CCND1_HUMAN 16 271 DBREF 2W9Z B 1 44 UNP P11802 CDK4_HUMAN 1 44 DBREF 2W9Z B 48 303 UNP P11802 CDK4_HUMAN 48 303 DBREF 2W9Z B 304 309 PDB 2W9Z 2W9Z 304 309 SEQADV 2W9Z GLU B 43 UNP P11802 GLY 43 ENGINEERED MUTATION SEQADV 2W9Z GLU B 44 UNP P11802 GLY 44 ENGINEERED MUTATION SEQADV 2W9Z ALA B 172 UNP P11802 THR 172 ENGINEERED MUTATION SEQRES 1 A 257 MET ALA TYR PRO ASP ALA ASN LEU LEU ASN ASP ARG VAL SEQRES 2 A 257 LEU ARG ALA MET LEU LYS ALA GLU GLU THR CYS ALA PRO SEQRES 3 A 257 SER VAL SER TYR PHE LYS CYS VAL GLN LYS GLU VAL LEU SEQRES 4 A 257 PRO SER MET ARG LYS ILE VAL ALA THR TRP MET LEU GLU SEQRES 5 A 257 VAL CYS GLU GLU GLN LYS CYS GLU GLU GLU VAL PHE PRO SEQRES 6 A 257 LEU ALA MET ASN TYR LEU ASP ARG PHE LEU SER LEU GLU SEQRES 7 A 257 PRO VAL LYS LYS SER ARG LEU GLN LEU LEU GLY ALA THR SEQRES 8 A 257 CYS MET PHE VAL ALA SER LYS MET LYS GLU THR ILE PRO SEQRES 9 A 257 LEU THR ALA GLU LYS LEU CYS ILE TYR THR ASP ASN SER SEQRES 10 A 257 ILE ARG PRO GLU GLU LEU LEU GLN MET GLU LEU LEU LEU SEQRES 11 A 257 VAL ASN LYS LEU LYS TRP ASN LEU ALA ALA MET THR PRO SEQRES 12 A 257 HIS ASP PHE ILE GLU HIS PHE LEU SER LYS MET PRO GLU SEQRES 13 A 257 ALA GLU GLU ASN LYS GLN ILE ILE ARG LYS HIS ALA GLN SEQRES 14 A 257 THR PHE VAL ALA LEU CYS ALA THR ASP VAL LYS PHE ILE SEQRES 15 A 257 SER ASN PRO PRO SER MET VAL ALA ALA GLY SER VAL VAL SEQRES 16 A 257 ALA ALA VAL GLN GLY LEU ASN LEU ARG SER PRO ASN ASN SEQRES 17 A 257 PHE LEU SER TYR TYR ARG LEU THR ARG PHE LEU SER ARG SEQRES 18 A 257 VAL ILE LYS CYS ASP PRO ASP CYS LEU ARG ALA CYS GLN SEQRES 19 A 257 GLU GLN ILE GLU ALA LEU LEU GLU SER SER LEU ARG GLN SEQRES 20 A 257 ALA GLN GLN ASN MET ASP PRO LYS ALA ALA SEQRES 1 B 306 MET ALA THR SER ARG TYR GLU PRO VAL ALA GLU ILE GLY SEQRES 2 B 306 VAL GLY ALA TYR GLY THR VAL TYR LYS ALA ARG ASP PRO SEQRES 3 B 306 HIS SER GLY HIS PHE VAL ALA LEU LYS SER VAL ARG VAL SEQRES 4 B 306 PRO ASN GLY GLU GLU GLY LEU PRO ILE SER THR VAL ARG SEQRES 5 B 306 GLU VAL ALA LEU LEU ARG ARG LEU GLU ALA PHE GLU HIS SEQRES 6 B 306 PRO ASN VAL VAL ARG LEU MET ASP VAL CYS ALA THR SER SEQRES 7 B 306 ARG THR ASP ARG GLU ILE LYS VAL THR LEU VAL PHE GLU SEQRES 8 B 306 HIS VAL ASP GLN ASP LEU ARG THR TYR LEU ASP LYS ALA SEQRES 9 B 306 PRO PRO PRO GLY LEU PRO ALA GLU THR ILE LYS ASP LEU SEQRES 10 B 306 MET ARG GLN PHE LEU ARG GLY LEU ASP PHE LEU HIS ALA SEQRES 11 B 306 ASN CYS ILE VAL HIS ARG ASP LEU LYS PRO GLU ASN ILE SEQRES 12 B 306 LEU VAL THR SER GLY GLY THR VAL LYS LEU ALA ASP PHE SEQRES 13 B 306 GLY LEU ALA ARG ILE TYR SER TYR GLN MET ALA LEU ALA SEQRES 14 B 306 PRO VAL VAL VAL THR LEU TRP TYR ARG ALA PRO GLU VAL SEQRES 15 B 306 LEU LEU GLN SER THR TYR ALA THR PRO VAL ASP MET TRP SEQRES 16 B 306 SER VAL GLY CYS ILE PHE ALA GLU MET PHE ARG ARG LYS SEQRES 17 B 306 PRO LEU PHE CYS GLY ASN SER GLU ALA ASP GLN LEU GLY SEQRES 18 B 306 LYS ILE PHE ASP LEU ILE GLY LEU PRO PRO GLU ASP ASP SEQRES 19 B 306 TRP PRO ARG ASP VAL SER LEU PRO ARG GLY ALA PHE PRO SEQRES 20 B 306 PRO ARG GLY PRO ARG PRO VAL GLN SER VAL VAL PRO GLU SEQRES 21 B 306 MET GLU GLU SER GLY ALA GLN LEU LEU LEU GLU MET LEU SEQRES 22 B 306 THR PHE ASN PRO HIS LYS ARG ILE SER ALA PHE ARG ALA SEQRES 23 B 306 LEU GLN HIS SER TYR LEU HIS LYS ASP GLU GLY ASN PRO SEQRES 24 B 306 GLU HIS HIS HIS HIS HIS HIS FORMUL 3 HOH *222(H2 O) HELIX 1 1 LEU A 22 THR A 37 1 16 HELIX 2 2 SER A 43 VAL A 48 1 6 HELIX 3 3 LEU A 53 GLN A 71 1 19 HELIX 4 4 GLU A 76 SER A 90 1 15 HELIX 5 5 LYS A 95 SER A 97 5 3 HELIX 6 6 ARG A 98 GLU A 115 1 18 HELIX 7 7 THR A 120 THR A 128 1 9 HELIX 8 8 ARG A 133 LEU A 148 1 16 HELIX 9 9 THR A 156 LYS A 167 1 12 HELIX 10 10 ALA A 171 THR A 191 1 21 HELIX 11 11 VAL A 193 ASN A 198 1 6 HELIX 12 12 PRO A 199 SER A 219 1 21 HELIX 13 13 PHE A 223 TYR A 227 5 5 HELIX 14 14 ARG A 228 ILE A 237 1 10 HELIX 15 15 ASP A 240 GLN A 264 1 25 HELIX 16 16 PRO B 50 ARG B 62 1 13 HELIX 17 17 LEU B 63 GLU B 67 5 5 HELIX 18 18 LEU B 100 LYS B 106 1 7 HELIX 19 19 ALA B 114 ASN B 134 1 21 HELIX 20 20 LEU B 161 SER B 166 1 6 HELIX 21 21 TYR B 167 ALA B 172 1 6 HELIX 22 22 ALA B 182 GLN B 188 1 7 HELIX 23 23 THR B 193 PHE B 208 1 16 HELIX 24 24 SER B 218 GLY B 231 1 14 HELIX 25 25 GLU B 265 LEU B 276 1 12 HELIX 26 26 SER B 285 LEU B 290 1 6 SHEET 1 BA 5 GLU B 7 GLY B 15 0 SHEET 2 BA 5 GLY B 18 ARG B 24 -1 O GLY B 18 N GLY B 15 SHEET 3 BA 5 PHE B 31 PRO B 40 -1 O VAL B 32 N ALA B 23 SHEET 4 BA 5 GLU B 86 GLU B 94 -1 O ILE B 87 N VAL B 39 SHEET 5 BA 5 LEU B 74 ARG B 82 -1 N MET B 75 O VAL B 92 SHEET 1 BB 3 GLN B 98 ASP B 99 0 SHEET 2 BB 3 ILE B 146 VAL B 148 -1 O VAL B 148 N GLN B 98 SHEET 3 BB 3 LYS B 155 LEU B 156 -1 O LYS B 155 N LEU B 147 CISPEP 1 ALA B 2 THR B 3 0 0.90 CISPEP 2 LEU B 112 PRO B 113 0 -2.86 CISPEP 3 GLU B 235 ASP B 236 0 4.63 CISPEP 4 ARG B 246 GLY B 247 0 4.16 CISPEP 5 VAL B 261 PRO B 262 0 -2.56 CISPEP 6 PRO B 262 GLU B 263 0 19.59 CRYST1 57.198 65.011 188.699 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017483 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015382 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005299 0.00000